Prescription Drug Monitoring Program Advisory Commission Clinical Review Subcommittee meets January 8

What: The first public meeting of the Prescription Drug Monitoring Program (PDMP) Advisory Commission Clinical Review Subcommittee

Agenda: Review statute creating and directing the subcommittee; review and discuss draft charter; review and discuss prescription data with PDMP staff; make recommendations and assignments

When: Monday, Jan. 8, 2-4 p.m. A public comment period is offered at the end of the meeting.

Where: Portland State Office Building, 800 NE Oregon St., Room 918 (ninth floor), Portland

Background: Oregon HB 3440, passed in 2017, requires that the Oregon Health Authority, in conjunction with the PDMP Advisory Commission, establish a clinical review subcommittee to identify practitioners who are prescribing high amounts of opioids based on agreed-upon practice standards such as the Oregon Opioid Prescribing Guidelines for chronic pain. These providers are to receive education or training related to pain management and appropriate opioid prescribing.

Program contact: Drew Simpson, 971-673-1033, [email protected]

# # #

Links:
· PDMP Advisory Commission: http://www.orpdmp.com/advisory-board/
· Oregon Opioid Prescribing Guidelines: http://www.oregon.gov/obnm/rules/opioidprescribingguidelines.pdf

Everyone has a right to know about and use the Oregon Health Authority (OHA) Programs and services. OHA provides free help. Some examples of the free help OHA can provide are:
· Sign language and spoken language interpreters
· Written material in other languages
· Braille
· Large print
· Audio and other formats

If you need help or have questions, please contact Drew Simpson, 971-673-1033; [email protected] at least 48 hours before the meeting.
Contact Info:
Contact: Jonathan Modie, 971-246-9139, [email protected]

OHA External Relations,[email protected]